Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

9.9K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcoma.

Nature communications·2026
Same author

Attribute-Weighted Aggregation of Tandem Mass Reporter Ion Intensity for Protein Quantification Using Isobaric Labeling.

Journal of proteome research·2025
Same author

Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis.

Communications biology·2025
Same author

Structural basis of TMPRSS11D specificity and autocleavage activation.

Nature communications·2025
Same author

Author Correction: Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.

Nature communications·2025
Same author

ImmunoTar-integrative prioritization of cell surface targets for cancer immunotherapy.

Bioinformatics (Oxford, England)·2025

Related Experiment Video

Updated: Feb 23, 2026

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.8K

Using Public Data for Comparative Proteome Analysis in Precision Medicine Programs.

Christopher S Hughes1, Gregg B Morin1,2

  • 1Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

Proteomics. Clinical Applications
|September 10, 2017
PubMed
Summary
This summary is machine-generated.

Publicly available mass-spectrometry proteomics data enables robust comparisons for precision medicine. This approach allows for effective analysis of cell lines and tumor tissues, aiding disease phenotype identification.

Keywords:
isobaric tagginglabel free quantificationmass spectrometryprecision medicine

More Related Videos

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

1.4K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.6K

Related Experiment Videos

Last Updated: Feb 23, 2026

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.8K
A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

1.4K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.6K

Area of Science:

  • Proteomics
  • Precision Medicine
  • Bioinformatics

Background:

  • Longitudinal precision medicine programs require comparative analyses to maximize clinical utility.
  • Identifying disease-driving biological features necessitates robust comparisons with existing data.

Purpose of the Study:

  • To investigate the utility of public mass-spectrometry-based proteomics data for inter-study comparisons.
  • To assess the robustness of comparing proteomics studies using different methodologies.

Main Methods:

  • Utilized publicly deposited mass-spectrometry proteomics data.
  • Included data from label-free (MS1) and isobaric tagging (MS2 and MS3) quantification methods.
  • Analyzed ovarian cancer cell lines and tumor tissues.

Main Results:

  • Demonstrated robust recapitulation of gene expression dynamics across studies with different methodologies.
  • Enabled robust inter-study clustering of cell line samples.
  • Established the ability to classify and cluster tumor samples using single-patient data against repository data.

Conclusions:

  • State-of-the-art mass-spectrometry proteomics data can serve as a resource for robust comparative analyses in precision medicine.
  • This approach enhances the identification of underlying features driving disease phenotypes.